Evidence map›Paper›PMID 31766758›Full record

ReviewInternational journal of molecular sciences2019

Giulia Degiacomi, José Camilla Sammartino, Laurent Roberto Chiarelli, Olga Riabova, Vadim Makarov, Maria Rosalia Pasca

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 147 citations in OpenAlex.

  1. Article
  2. Ribosome hibernation in zinc-starvedMicrobiology spectrum · 2026
    Article
  3. Article
  4. Genomic Characterization and Taxonomic Classification ofInternational journal of molecular sciences · 2026
    Article
  5. From colonisation to chronicity: adaptation ofMicrobiology (Reading, England) · 2026
    Article
  6. Review
  7. Phosphatidylserine liposomes forFrontiers in immunology · 2026
    Article
  8. Article
  9. Article
  10. Interplay ofVirulence · 2025
    Article
  11. Article
  12. Article
  13. Shallow metagenomic shotgun sequencing improves detection of pathogenic species in cystic fibrosis respiratory samples.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2025
    Article
  14. P3MA: A Promising Mycobacteriophage InfectingAntibiotics (Basel, Switzerland) · 2025
    Article
  15. Article
  16. Article
  17. State-of-the-Art Review: Transformative Changes in the Care of People With Cystic Fibrosis: Implications for Infectious Diseases Specialists.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Review
  18. Article
  19. Article
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Giulia DegiacomiDepartment of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, 27100 Pavia, Italy.
José Camilla SammartinoDepartment of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, 27100 Pavia, Italy.
Laurent Roberto ChiarelliDepartment of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, 27100 Pavia, Italy.
Olga RiabovaBach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow 119071, Russia.
Vadim MakarovBach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow 119071, Russia.
Maria Rosalia PascaDepartment of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, 27100 Pavia, Italy.
University of Pavia · ITA N Bach Institute of Biochemistry · RU

Funding

Fondazione per la Ricerca sulla Fibrosi Cistica FFC#19/2018
6 · The paper itself

Abstract

Nontuberculous mycobacteria (NTM) have recently emerged as important pathogens among cystic fibrosis (CF) patients worldwide.

Indexed as

Communicable Diseases, EmergingCystic FibrosisMycobacterium abscessusMycobacterium Infections, NontuberculousPulmonary AlveoliAnimalsCystic Fibrosis Transmembrane Conductance RegulatorDisease Models, AnimalDrug Resistance, Multiple, BacterialHumansZebrafishCFTR protein, humanCystic Fibrosis Transmembrane Conductance Regulatorcystic fibrosisdrug resistanceMycobacterium abscessusnontuberculous mycobacteria

Identifiers

PMID31766758
PMCPMC6928860
OpenAlexW2991337044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.